| 000 | 01505 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517093823.0 | ||
| 264 | 0 | _c20180214 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1815-7920 | ||
| 024 | 7 |
_a10.5588/ijtld.15.0006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolland, D P | |
| 245 | 0 | 0 |
_aTackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis. _h[electronic resource] |
| 260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _c06 2016 |
||
| 300 |
_a827-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDecision Support Techniques |
| 650 | 0 | 4 |
_aEthambutol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 |
_aPyrazinamide _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRifampin _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aHamilton, C D | |
| 700 | 1 | _aStout, J E | |
| 773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 20 _gno. 6 _gp. 827-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5588/ijtld.15.0006 _zAvailable from publisher's website |
| 999 |
_c25997198 _d25997198 |
||